Table 1.
Per study site | Per country total | Study total |
|||
Phase 1 | Phase 2 | Total | |||
Patient questionnaire | ~300, to recruit 100 UTI+ | ~300, to recruit 100 UTI+ | ~600, to recruit 200 UTI+ | ~1800, to recruit 600 UTI+ | ~5400, to recruit 1800 UTI+ |
Household questionnaire | 100 | 100 | 200 | 600 | 1800 |
Patient IDIs | 5 | 5 | 10 | 30 | 90 |
Healthcare worker IDIs | 1–5 | 0–5 to fill quota | 5 | 15 | 45 |
Drug seller mystery client study visits | – | 50 | 50 | 150 | 450 |
Drug seller IDIs | – | 10 | 10 | 30 | 90 |
Focus group discussions | – | 4–8 | 4–8 | 12–24 | 36–72 |
HATUA, Holistic Approach to Unravel Antibacterial Resistance in East Africa; IDI, in-depth interview; UTI, urinary tract infection.